US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India’s pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports. Post navigation आज से शुरू हो रहा स्टार्टअप महाकुंभ:इसमें 3 हजार से ज्यादा स्टार्टअप्स शामिल हो रहे, पीयूष गोयल सुबह 11 बजे इनॉगरेशन करेंगे Donald Trump reciprocal tariffs: Why India’s agricultural exports are likely to be little affected
